1. Laurus Labs
Laurus Labs Share Price

Laurus Labs Share Price

NSE: LAURUSLABS | BSE: 540222 | Pharmaceuticals

45% Sell

₹597.05

+₹3.80 (0.64%) Last updated on 21 May, 2025 | 15:58 IST

Laurus Labs Overview

Market cap
Market Cap Switch₹32,008 Crs
Open
₹596.00
Prev. Close
₹593.25
Circuit range
₹652.55 - ₹533.95
Day range
₹593.10 - ₹603.25
Year range
₹385.45 - ₹660.90
Volume
15,09,612
Avg. traded
₹597.26
Revenue (12m)
₹5,554 Crs

About Laurus Labs

Laurus Labs is an Indian pharmaceutical and biotechnology company. It is headquartered in Hyderabad and was founded in 2005.

Initially founded as a CRAMS (contract research and manufacturing services) enterprise, the company swiftly diversified into antiretroviral drugs (ARVs). Within five years, it transitioned into a respected active pharmaceutical ingredients (API) focused company. Another half-decade later, Laurus Labs expanded into a fully integrated pharmaceutical company.

The market capitalisation of Laurus Labs Limited is over ₹22,600 crore as of January 10, 2024. Laurus Labs share price has gained over 18% in the last three years.

Business operations

Laurus Labs specialises in the development, production and distribution of pharmaceutical ingredients and their related intermediates worldwide. It also offers a range of services to the global pharmaceutical industry, including drug discovery, medicinal chemistry, lead optimisation, process development, scale-up, safety assessment, formulation development and analytical chemistry services for its clientele.

Laurus Labs operates through three primary business segments. Firstly, Laurus Generics focuses on the development, manufacturing, and sale of APIs and advanced intermediates, along with oral solid formulations and finished dosage forms (FDFs). Secondly, Laurus Synthesis specialises in key starting materials (KSM), intermediates and APIs, particularly for new chemical entities (NCEs). Laurus Bio concentrates on recombinant products, producing animal-origin-free products for safer and virus-free bio-manufacturing processes.

Laurus Limited collaborates with the top 10 global generic pharmaceutical companies, distributing its APIs across 56 countries. The company concentrates primarily on developing anti-retroviral, Hepatitis C and oncology drugs.

Laurus Limited is also deeply involved in the research and development (R&D) in high-growth potential areas. With a total of 322 filed patents, it currently owns 203. Over its operational tenure, Laurus Limited has successfully brought more than 60 products to market, spread across three distinct business segments: Generics API, generics finished dosage form (FDF) and synthesis.

The company has over 55 state-of-the-art R&D labs strategically positioned in India and the US. It manufactures a staggering 90-plus APIs across ten cutting-edge manufacturing facilities which have over 7 million litres of reactor capacity. The company has a workforce comprising over 5,000 professionals, among which 800-plus are dedicated research scientists. This team serves more than 200 customers spread across 56 countries.

Laurus Labs has API manufacturing facilities in Visakhapatnam, an FDF drug manufacturing facility situated in Achutapuram and a research and development centre at IKP Knowledge Park in Hyderabad. The Hyderabad centre is also approved by the Department of Scientific and Industrial Research, Ministry of Science and Technology of India (DSIR).

With its manufacturing and R&D, Laurus is among the global leaders in supplying anti-retroviral APIs and intermediates. Its cost-effective technologies contribute to improving access to affordable medication worldwide. Oncology is Laurus Limited's key strength. It offers an extensive range of APIs in this domain. Laurus consistently expands its portfolio and its focus extends to molecules in diabetes, ophthalmology and cardiovascular therapy areas.

Financial highlights

Laurus Labs Limited's revenue from operations for FY23 stood at ₹6,040.55 crore, up by 22.4%, as compared to ₹4,935.57 crore in FY22. The net profit after tax for FY23 was ₹793.43 crore compared to ₹832.23 crore during the previous year. In FY23, the earnings before interest, tax, depreciation and amortisation (EBITDA) increased to ₹1,594 crore from the previous year's ₹1,436 crore. The company's earnings per share (EPS) stood at ₹14.69 in FY23 compared to ₹15.42 in FY22.

  • Chart
  • Fundamentals
  • Financials
  • F&O
  • Shareholdings
  • Events
  • Peers
  • News
  • FAQs

Laurus Labs Share Price Chart

Please wait...

Laurus Labs Key Indicators

P/E ratio
89.34
P/B ratio
7.45
ROE
5.44%
ROCE
7.54%
Dividend yield
0.19%
Debt/Equity ratio
0.49
EPS
4.15

Investment Checklist: (4/6)

passed

Equity returns

not passed

Dividend returns

passed

Safety factor

passed

Growth factor

passed

Debt vs Equity

NA

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst Ratings:

Sell

Buy

36%

Hold

19%

Sell

45%

This analysis is based on the reviews of 11 experts in the last 7 days

Laurus Labs Financial Ratios

  • Profitability

  • Operational

  • Valuation

Operating profit margin

16.57%

Net profit margin

4.65%

ROE

5.44%

ROA

2.77%

ROCE

7.54%

Laurus Labs Shareholder returns

1 day
-2.32%
1 week
-0.34%
1 month
-5.54%
3 months
+10.53%
1 year
+33.42%
3 years
+3.26%
5 years
+546.38%

Revenue Statement

All values are in ₹ Crores (Cr)
RevenueNo Sort
Operating ProfitNo Sort
Net ProfitNo Sort
Mar-24
5,040.83
803.84
168.21
Mar-23
6,040.55
1,598.19
796.64
Mar-22
4,935.57
1,437.73
832.43
Mar-21
4,813.51
1,574.34
983.82

Cash Flow

All values are in ₹ Crores (Cr)
OperatingNo Sort
InvestingNo Sort
FinancingNo Sort
Mar-24
665.69
-822.42
249.83
Mar-23
993.90
-996.06
-26.64
Mar-22
911.10
-914.34
30.26
Mar-21
733.00
-940.99
254.70

Balance Sheet

All values are in ₹ Crores (Cr)
Total AssetNo Sort
Total LiabilityNo Sort
Mar-24
8,387.03
4,271.46
Mar-23
7,660.40
3,611.74
Mar-22
6,968.04
3,608.99
Mar-21
5,750.69
3,149.99

Laurus Labs Share Price History

DayOpenCloseChange %
20-May-25
₹609.95
₹593.25
-2.32%
19-May-25
₹603.00
₹607.35
+0.71%
16-May-25
₹607.10
₹603.05
-0.11%
15-May-25
₹610.00
₹603.70
-0.37%
14-May-25
₹596.65
₹605.95
+1.80%
13-May-25
₹595.95
₹595.25
+0.30%
12-May-25
₹597.70
₹593.45
+0.79%
09-May-25
₹578.00
₹588.80
+0.35%

Laurus Labs Shareholding Pattern

Promoters (27.62%)

Mutual Funds (6.88%)

Retail and other (35.09%)

Foreign institutions-FII (25.51%)

Other domestic institutions (4.9%)

Retail and other

Corporate Actions

  • Dividend • ₹0.8/share

    Ex date 09 May 2025

    expand tab
  • Dividend • ₹0.4/share

    Ex date 06 Nov 2024

    expand tab
  • Dividend • ₹0.4/share

    Ex date 08 May 2024

    expand tab
  • Dividend • ₹0.4/share

    Ex date 02 Nov 2023

    expand tab

Stocks Similar to Laurus Labs

PriceNo Sort
Change %No Sort
Abbott India₹31,400.00+₹555.00 (1.80%)
Ajanta Pharma₹2,637.90+₹38.90 (1.50%)
Alkem Laboratories₹5,374.00+₹115.00 (2.19%)
GlaxoSmithKline Pharma₹2,984.20+₹197.60 (7.09%)
Lupin₹1,996.00+₹29.10 (1.48%)
Natco Pharma₹875.60+₹23.60 (2.77%)
Pfizer₹4,978.90+₹29.10 (0.59%)
Sanofi India₹6,377.00+₹73.50 (1.17%)

Popular Stocks

PriceNo Sort
Change %No Sort
HDFC Bank₹1,926.80+₹11.90 (0.62%)
Indian Energy Exchange₹199.18+₹1.73 (0.88%)
Indian Railway Tourism Corp₹790.20+₹4.45 (0.57%)
Infosys₹1,568.50+₹7.90 (0.51%)
ITC₹433.00-₹1.90 (-0.44%)
JIO FIN SERVICES LTD₹274.35+₹2.90 (1.07%)
Reliance₹1,429.20+₹4.60 (0.32%)
Tata Motors₹726.80+₹7.90 (1.10%)
Tata Power₹401.85+₹2.90 (0.73%)
Wipro₹250.92+₹1.21 (0.48%)

FAQs on Laurus Labs

What is the share price of Laurus Labs today?

chevron-up
Laurus Labs share price is ₹ 597.05 as on 21 May, 2025 | 15:58 IST.

What are the high & low stock price of Laurus Labs today?

chevron-up
Laurus Labs stock price hit a high of ₹ 603.25 and low of ₹ 593.10 as on 21 May, 2025 | 15:58 IST.

What is the market cap of Laurus Labs?

chevron-up
The market cap of Laurus Labs is ₹ 32,008.16 Crores as on 21 May, 2025 | 15:58 IST.

What are the the 52-week high and low share prices of Laurus Labs stock on the NSE?

chevron-up
52-week high stock Price of Laurus Labs is ₹ 660.90 and Low Price is ₹ 385.45 as on 21 May, 2025 | 15:58 IST.

What are the stock symbols of Laurus Labs?

chevron-up
The stock symbol of Laurus Labs is NSE: LAURUSLABS on the NSE and BSE: 540222 on the BSE, and the ISIN is INE947Q01028.

Can I buy Laurus Labs shares on Holidays?

chevron-up
No, shares of Laurus Labs or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Laurus Labs shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.

What is the PE and PB ratio of Laurus Labs?

chevron-up
The PE and PB ratio of Laurus Labs is 89.34 and 7.45 respectively, as on 21 May, 2025 | 15:58 IST.

What are the returns on Laurus Labs shares?

chevron-up
The historical returns for Laurus Labs shares are 33.42 for 1 year, 3.26 for 3 year and 546.38 for 5 year.